TheresaHuaShaoMD

Oncology • New York, NY

Assistant Professor, Medicine, Oncology, Albert Einstein College of Medicine

Join to view full profile

Dr. Shao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shao's full profile

Already have an account?

Office
325 W 15th St
New York, NY 10011
Phone+1 212-604-6058

Fax+1 212-604-6039

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2007 - 2010
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2004 - 2007
Perelman School of Medicine at the University of PennsylvaniaClass of 2004

Certifications & Licensure

NY State Medical License 2005 - 2025
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2011 May 02
Active, not recruiting
Phase 1

Publications & Presentations

PubMed

645 citations
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
Dawn L. Hershman, Theresa Shao, Lawrence H. Kushi, Donna Buono, Wei-Yann Tsai
Breast Cancer Research and Treatment. 2011-04-01
38 citations
Prevention of Bone Loss by Zoledronic Acid in Premenopausal Women Undergoing Adjuvant Chemotherapy Persist up to One Year following Discontinuing Treatment
Dawn L. Hershman, Donald J. McMahon, Katherine D. Crew, Theresa Shao, Serge Cremers
The Journal of Clinical Endocrinology and Metabolism. 2010-02-01
624 citations
Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients
Dawn L. Hershman, Lawrence H. Kushi, Theresa Shao, Donna Buono, Aaron Kershenbaum
Journal of Clinical Oncology. 2010-09-20

Press Mentions

Woman Battling Stage 4 Breast Cancer After Delayed Screenings Amid PandemicOctober 18th, 2021